Roel Funke
IGM Biosciences (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Initial sequencing and analysis of the human genome(2001)24,450 cited
- → Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer(2018)4,261 cited
- → Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma(2016)702 cited
- → Why animals have different muscle fibre types(1988)391 cited
- → Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up(2018)278 cited
- → Non-viral precision T cell receptor replacement for personalized cell therapy(2022)256 cited
- → Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)(2018)237 cited
- → FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC(2018)169 cited
- → The Influence of Temperature on Muscle Velocity and Sustained Performance in Swimming Carp(1990)140 cited
- → EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation(2008)132 cited